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Given an equal sex ratio at conception, we can only explain the excess of human males at birth by greater 31 
loss of females during pregnancy. I propose that the bias against females during human development is the 32 
result of a greater degree of genetic and metabolic “differentness” between female embryos and maternal 33 
tissues than for similarly aged males, and that successful implantation and placentation represents a threshold 34 
dichotomy, where the acceptance threshold shifts depending on maternal condition, especially stress. Right 35 
and left ovaries are not equal, and neither are the eggs and follicular fluid that they produce, and I further 36 
hypothesise that during times of stress, the implantation threshold is shifted sufficiently to favour survival of 37 
females, most likely those originating from the right ovary, and that this, rather than simply a greater loss of 38 























The choosy uterus 60 
Pregnancy can in part be viewed as a conflict between mother and offspring.[1] Selection acts on maternal 61 
genes to limit the supply of resources to developing offspring so as to maximise (or at least stabilise) 62 
maternal fitness, whereas fetal genes are selected to maximise growth.[1, 2] These selfish offspring may seek 63 
to maximise their own growth at the expense of future offspring, whereas maternal investment may vary with 64 
age, with younger mothers less likely, and older mothers more likely, to sacrifice their well-being for the 65 
benefit of their offspring.[3, 4] Imprinting of maternal genes therefore serves to control the growth and/or 66 
function of the placenta. There is also potential conflict between maternal and paternal alleles, as fathers 67 
have an interest in improved survival of (their) current offspring even at the expense of future offspring, 68 
which may have a different father. With respect to offspring sex ratios, the Trivers and Willard Hypothesis 69 
proposes that as females deviate from the “average” condition they should bias the production of one sex 70 
over the other, driven by improved likelihood of producing grandchildren,[5] and logic suggests that this sex 71 
ratio manipulation should occur early to minimise wasted maternal investment. In humans, the sex ratio at 72 
birth is male-biased, with around 1,055 males born per 1,000 females in England and Wales between 1927 73 
and 2007 (Figure 1). Since implantation represents the first major instance of fetal-maternal conflict, I 74 
hypothesise that it is at this point that a large component of variation in the human sex ratio arises, facilitated 75 
by sensing of embryo quality by the uterine lining (endometrium),[6–9] most specifically the degree of 76 
“differentness” from the mother. Implantation therefore represents a threshold dichotomy,[10] where passing 77 
the threshold results in successful implantation and initiation of placentation (and at least a chance of further 78 
development) and failing results in loss, but where the threshold itself can vary within and between women. 79 
The mammalian implantation process is thought to have evolved from endometrial inflammation – a natural 80 
reaction of maternal tissues to a foreign body.[11, 12] Whilst the initial stages of implantation are pro-81 
inflammatory, post-implantation embryonic development requires an anti-inflammatory endometrial state, 82 
and there must therefore be a point of acceptance by the maternal tissues either at initial contact, or soon 83 
after as the embryo “invades” the endometrium and as the process of placentation progresses.[7] The first few 84 
weeks of gestation place relatively little demand upon the mother and therefore involve little maternal 85 
investment, and so embryo quality control should occur early, with the fetal-maternal interface (i.e. the 86 
interaction between fetal ligands and maternal receptors) representing the front line in the battle between 87 
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invading trophoblast and defending maternal tissues. Indeed, discussion of early fetal-maternal interactions is 88 
full of references to embryonic “invasion” of the endometrium, and the literature is full of war-like 89 
references to “fighting lines”,[13] “no man’s land”,[14] and the embryo as a “deceitful and treacherous 90 
enemy”.[15] A more appropriate comparison for the very earliest stages of implantation at or soon after the 91 
initiation of embryo-maternal contact may be an interview, where the embryo seeks to make a favourable 92 
impression.[14] The evolution of deeper implantation in placental mammals facilitated more thorough vetting 93 
of offspring, and these deeper forms of implantation may have evolved to reduce the “ease” by which a 94 
mother may reject an embryos through sloughing of superficial layers of endometrium.[14] This process, 95 
together with rapid evolution of placental proteins[3] reflects the fetal-maternal arms race. How might this 96 
maternal vetting of embryos occur, and why might it preferentially target female embryos to result in a male-97 
biased sex ratio at birth? 98 
Male and female embryos differ from the very point of conception. Only males can express genes on the Y 99 
chromosome, and, prior to the completion of X chromosome inactivation, females can produce up to twice 100 
the amount of gene product for any gene encoded by the X chromosome. Male and female embryos therefore 101 
express different genes even at very early stages, varying from around 600 differentially-expressed genes in 102 
mouse blastocysts,[16] to up to a third (2,921) of expressed transcripts in cow.[17] Errors or delays in X 103 
chromosome inactivation, such as skewed (non-random) inactivation of the paternal or maternal copy, are 104 
likely to lead to increased fetal-maternal “differentness” and therefore preferential loss of female embryos. 105 
Indeed, such skewed inactivation has previously been implicated in recurrent miscarriage (typically defined 106 
as three or more consecutive miscarriages before 20 weeks), although evidence for this is often 107 
contradictory.[18, 19] Male embryos grow faster,[20, 21] and so a female embryo will be ready for implantation 108 
later than an identically-aged male, and is more likely to miss the implantation window when the 109 
endometrium is most receptive (a period of around 4 days, typically 6-8 days post-ovulation[22]). Male and 110 
female embryos are also metabolically distinct, as females are thought to make more use of the pentose 111 
phosphate pathway, possibly because of an additional copy of the X-linked G6PD1 gene,[21] although others 112 
have cast doubt on this idea.[23] Metabolism is likely the most fundamental difference between early male and 113 
female embryos, and certainly one of the most dynamic,[24] and metabolically “quiet” embryos may survive 114 
better than more active ones.[25–27] In this “quiet embryo hypothesis”, metabolic signatures of the embryo are 115 
assumed to reflect viability, for instance levels of DNA damage,[26] with maternal selection against 116 
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metabolically-active (putatively less viable) embryos. Of course, this quest for quietness, if taken too far, 117 
would ultimately result in embryonic death, and so there must be a window of viability within which 118 
successful embryos must operate. Accepting that the endometrium acts as a biosensor to reject “unsuitable” 119 
embryos,[6–8] and that there may be a “Goldilocks zone” of embryonic potential,[28] females may be 120 
discriminated against from the very earliest stages of their development as early female embryos may be 121 
more different to their mother than their male counterparts. Although males have Y chromosome-specific 122 
genes that the mother does not herself possess, the X chromosome encodes more genes (846 to the 63 on the 123 
Y chromosome in Ensembl release GRCh38.p12), and prior to completion of X chromosome inactivation 124 
differential gene expression is therefore greater in females. Genes on sex chromosomes are known to 125 
regulate autosomal genes,[23] and the greater number of X-linked genes in females will have a concomitantly 126 
larger effect on the number of downstream autosomal genes that are up- or down-regulated. Male and female 127 
embryos are both genetically distinct from their mother (i.e. encode paternally-derived genes), but again, 128 
because of the size of the X chromosome, females have a greater amount of paternal DNA (the X is 156Mb 129 
long, the Y just 57Mb, which may have relevance for the extent of imprinting), and a greater number of 130 
paternal genes.  131 
A comprehensive study of the human sex ratio from conception to birth[29] shows an initial large loss of male 132 
embryos in the first week or so, followed by a longer period of female-biased loss in the first trimester. As a 133 
result, the cohort sex ratio is male-biased from the end of the first trimester, and remains this way until the 134 
last few weeks of pregnancy, where male-biased stillbirth[30] likely comes into play. The greatest number of 135 
female losses therefore occurs at or soon after implantation, and in the following weeks as placentation 136 
progresses. It is here that maternal-fetal contact is both established and, through placentation, extended, to 137 
reach the closest possible juxtaposition of maternal and fetal tissues and blood supplies, and this period also 138 
represents one of relatively limited fetal growth and maternal investment. It is no surprise that this should 139 
represent the “interview” period. Even once the interview is passed, the endometrium may still present a 140 
more hostile environment to female embryos, which may go some way to explaining sex differences in the 141 
male and female placenta, where female placentae are more sensitive to perturbation in the peri-conception 142 
period, and show reduced growth and a greater amount of variation in placental gene and protein 143 




What is the extent of sex-biased loss in human pregnancy? 146 
Whilst 10% of clinically-recognised pregnancies end in miscarriage, the true number is estimated to be much 147 
higher as many pregnancies are lost before they are identified, and up to one third of all pregnancies may end 148 
in spontaneous abortion (miscarriage).[33–35] However, far higher values have been proposed.[29, 36, 37] In 1975, 149 
Roberts and Lowe attempted to predict the annual number of conceptions in England and Wales in 1971,[38] 150 
and suggested that up to 78% of conceptions were “lost” (unaccounted for in live birth and still birth 151 
records). Their analysis was based only on married women, hypothesised a mean frequency of coitus twice a 152 
week (one in four of which was unprotected), and did not include data for pregnancies ending in elective or 153 
therapeutic abortion. Using data from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)[39] it is 154 
possible to refine these calculations somewhat, and these updated calculations suggest that the assumption 155 
that around a third of all conceptions might be lost is valid (Box 1, Table 1). 156 
In England and Wales, all live births and stillbirths must be registered, and there is extensive historical data 157 
available on numbers of live births and stillbirths, including sex ratios (it should be noted however that in 158 
October 1992, the Stillbirth (Definition) Act 1992 changed the gestation cut-off for stillbirths from 28 or 159 
more weeks of gestation to 24 or more weeks, and so data from 1993 onwards is not comparable to previous 160 
years). In addition to extensive live birth and stillbirth data, the requirement that all practitioners in England 161 
and Wales who perform therapeutic or elective abortions must notify the Chief Medical Officer means that 162 
abortion statistics (including number of abortions by gestation week) are available going back to the late 163 
1960’s. The stability of the overall sex ratio at birth (Figure 1) suggests that, in England and Wales at least, 164 
there is no sex-selective abortion, and the general increase in the number of legal abortions, and the lack of 165 
maternal deaths due to complications of illegal abortions[40] also suggests that there are few if any unrecorded 166 
abortions. In England and Wales between 1993 and 2017 there were 16,489,289 maternities (a pregnancy 167 
resulting in the birth of one or more children including stillbirths, of which around 1.5% resulted in multiple 168 
births); 16,656,203 live births (8,114,739 female and 8,541,464 male, with on average 1,053 males born per 169 
1,000 females);  86,714 stillbirths (41,059 female and 45,655 male, with on average 1,112 males stillborn per 170 
1,000 females); 4,512,024 legal elective and therapeutic abortions, and 28,269,072 conceptions (assuming 171 
that 33% of conceptions result in spontaneous abortion (miscarriage) and that the recorded live birth, 172 
stillbirth and abortion figures therefore represent 67% of total conceptions). Historically, the male bias at 173 
birth was taken to result from the production of a greater proportion of males at conception, although more 174 
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recent data from in vitro fertilisation supports a balanced sex ratio at conception (see Orzack et al.[29] for 175 
discussion), as does the simple mechanics of equal segregation of X and Y chromosomes during 176 
spermatogenesis. We can therefore reasonably conclude that the 28,269,072 conceptions comprised equal 177 
numbers of males and females. If males and females were also equally represented in the therapeutic and 178 
elective abortion dataset (i.e.the abortus sex ratio is 50:50), then 2,256,012 males and 2,256,012 females 179 
were aborted. However, more recent work[29] supports a slightly female-biased cohort sex ratio during early 180 
pregnancy based on chorionic villus sampling, amniocentesis and induced abortions, and a conservative 181 
estimate of a 55:45 female:male sex ratio ≤12 weeks and 45:55 female:male ≥13 weeks might be more 182 
appropriate. In the study period, 4,044,380 therapeutic and elective abortions occurred ≤12 weeks of 183 
gestation and 467,644 occurred ≥13 weeks, with 2,435,740 girls aborted to 2,076,284 boys, for an average of 184 
853 boys aborted per 1,000 girls (Figure 2, Supplemental table S1). Using these data, it is possible to deduce 185 
that 28,269,072 conceptions resulted in 7,014,131 spontaneous abortions (miscarriages) in England and 186 
Wales between 1993 and 2017, with on average 141,720 females and 138,845 boys lost each year, for an 187 
average miscarriage sex ratio of 980 boys per 1000 girls (Supplemental table S2). Significantly more girls 188 
are lost during pregnancy (P < 0.00001, Pearson’s χ2 test). 189 
 190 
Stress, miscarriage, and variation in the sex ratio at birth 191 
The human sex ratio at birth is not stable, and, in England and Wales between 1993-2017, ranged from 1,047 192 
boys per 1,000 girls to 1,057 boys per 1,000 girls. The predicted miscarriage sex ratio over the same period, 193 
assuming equal numbers of males and females are conceived, ranged from 956 boys per 1,000 girls in 1993 194 
to almost parity (999 boys per 1,000 girls) in 2006 (Figure 3). The variation seen in 2006 follows the July 7th 195 
2005 terror attacks in London, and reflects the general observation that sex ratio varies following stressful 196 
events, and that parental hormone levels around conception in some ways influence the sex ratio of their 197 
offspring.[41–43] Why might stress impact the human sex ratio at birth, and what exactly is changing? 198 
The human stress response is mediated by the hypothalamic-pituitary-adrenal axis, and ultimately results in 199 
the release of glucocorticoid hormones (primarily cortisol) by the adrenal cortex. Interestingly, this process 200 
also results in release of progesterone by the adrenal cortex, and leads to increased circulating levels of 201 
progesterone in serum,[44] most likely because progesterone and cortisol are both cholesterol derivatives, and 202 
progesterone is a precursor in the synthesis of cortisol. Similarly, both testosterone and estradiol are 203 
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cholesterol-derivatives, and so production of these hormones may also increase during the stress response. 204 
The link between cholesterol, hormones, and changes to the sex ratio at birth are hinted at in differences in 205 
ABO blood group cholesterol levels and sex ratios,[45] and the link between cortisol and progesterone may 206 
also explain some seasonal variations in the human sex ratio at birth, as cortisol levels are known to vary 207 
throughout the year.[46] Such a link may in future be detectable through measurement of circulating hormone 208 
levels during early pregnancy, especially if linked to early (<12 weeks) detection of fetal sex using non-209 
invasive prenatal testing techniques (NIPT) and tracking of pregnancy outcome. If one of the factors 210 
involved in setting the threshold of acceptance for embryo implantation and peri-conception survival is the 211 
degree of differentness from the mother, then changes to hormone levels in the maternal circulation might 212 
alter the acceptance threshold, so embryos that previously would have been lost are now able to implant and 213 
survive. In particular, those female embryos produced from eggs originating in the right ovary, which would 214 
normally be rejected as too different might now survive in greater numbers.  215 
 216 
Ovarian asymmetry 217 
Humans demonstrate directional asymmetry, most obviously in the positioning of internal organs such as the 218 
heart, stomach and intestines. These asymmetries can ultimately be traced to determination of left-right axes 219 
during embryogenesis, dictated by left-biased ciliary flow and an ancient gene regulatory network involving 220 
PITX2, NODAL and LEFTY. Asymmetric PITX2 expression is maintained and plays a role in subsequent 221 
organ development, and, in birds,  underlies asymmetric development of the gonads, reaching its most 222 
extreme manifestation in the single (left) ovary and oviduct of many species.[47–49] Among mammals, 223 
functional asymmetry of left and right ovaries has been reported from many species, including mice,[50] 224 
shrews,[51] gerbils,[52] viscachia,[53, 54] bats,[55] and waterbuck.[56] Although human gonadal asymmetry is 225 
perhaps most apparent in males, where the right testis is larger, the inherent directional asymmetry of 226 
vertebrate embryos demonstrates that the human left and right ovary are not equal from the earliest stages of 227 
development. In adults, this asymmetry manifests itself in anatomical relations (the left ovary lies adjacent to 228 
the sigmoid colon, the right nearer the appendix), venous drainage (the left ovary drains into the left renal 229 
vein, the right into the inferior vena cava[57, 58]), and function. The right ovary may ovulate more frequently 230 
and favour pregnancy,[59–63] and this elevated function possibly leaves the right ovary more susceptible to 231 
ovarian cancer,[64, 65] cystic ovarian endometriosis,[66] and ruptured corpus luteum.[57, 67–69] Ectopic pregnancy 232 
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may also be more common on the right,[70–72] and gonadal tissues are unevenly distributed in true 233 
hermaphrodites, with ovaries more common on the left, and testes/ovotestes more common on the right.[73–75] 234 
The data on functional asymmetry of human ovaries and possible differential susceptibility to disease are 235 
noisy with generally small effects, however, the consistent trends, coupled with developmental and 236 
anatomical asymmetries, tells us that we should not consider left and right ovaries as equals. 237 
What implications might ovarian asymmetry have for human reproduction? There are hints in the literature 238 
that the right ovary might ovulate more, and favour pregnancy,[59–63] but one possibility that is generally 239 
neglected is that differences between left and right ovaries might lead to variation in the human sex ratio at 240 
birth. It has long been recognised that more males are born than females in many populations, despite greater 241 
susceptibility of boys to stillbirth,[30] (Figure 1). Whilst the sex ratio at birth is typically stable, and for the 242 
most part biased towards males, there is variation across populations, only some of which is likely due to 243 
sex-specific elective abortion.[76] The remaining variation can seemingly be explained by demography, with 244 
those of African origin having lower sex ratios[77, 78] (even becoming female-biased in some cases[77]), 245 
latitude,[79] and seasonality.[80–82] Perhaps most interestingly, the sex ratio at birth can be perturbed by 246 
stressful events, such as the 1995 Kobe earthquake;[83] famine;[84] war;[85–87] terrorist attacks;[88–90] historic 247 
royal events;[91] the Superbowl;[92] and economic stress.[93, 94] Such seasonal variation, coupled with the 248 
effects of stress, is evidence for hormonal influences on the human sex ratio at birth, and, indeed, it has 249 
previously been suggested that hormonal concentrations in parents around conception can alter sex ratios.[41, 250 
95] Once asymmetry of left and right ovaries is accepted, these influences may become easier to explain. The 251 
right and left ovaries differ in their venous drainage, and as a result, pressure in the right ovarian vein is 252 
higher than the left.[57, 58] The right ovary therefore drains more slowly than the left, and so we can expect 253 
hormones to accumulate differentially, resulting in higher concentrations of estradiol, testosterone, 254 
progesterone, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and cortisol on this side. These 255 
elevated concentrations are maintained, and perhaps boosted, by counter current exchange between ovarian 256 
veins and arteries.[96] Prior to ovulation, a human oocyte is bathed in approximately 5ml of follicular fluid, 257 
containing estradiol and progesterone in concentrations roughly 500x and 1000x higher respectively than in 258 
serum,[97–99] and the freedom of steroid hormones to move across membranes means that the oocyte will 259 
equilibrate to follicular fluid conditions prior to ovulation. Oocytes from the right and left ovaries will 260 
therefore experience different environments as folliculogenesis progresses, with levels of estradiol, 261 
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progesterone and others far in excess of maternal serum levels, and they will carry these hormones with them 262 
in their cytoplasm (and that of their companion cells) as they are released. At the same time, several 263 
millilitres of asymmetric follicular fluid is released, producing different microenvironments in the left and 264 
right fallopian tubes as the egg begins its journey towards fertilisation. 265 
 266 
Ovarian asymmetry and human reproduction 267 
Human sperm are attracted to follicular fluid.[100, 101] More specifically, a subset of sperm cells undergo 268 
capacitation, and as a result demonstrate chemotaxis,[102] with low levels of progesterone known to act as a 269 
chemoattractant.[103–105] There is some debate regarding the role that follicular fluid plays in vivo, with 270 
evidence from animal studies suggesting ≤1% of the follicular fluid released along with the egg actually 271 
enters the fallopian tube,[106–109] equating to ≤50µl in humans. Others have suggested that follicular fluid is 272 
the major fluid constituent in fallopian tubes immediately post-ovulation, as the egg is carried into the tube 273 
via a wave of fluid.[110] Follicular fluid that does not directly enter the fallopian tube is released into the 274 
peritoneal cavity immediately adjacent to the ovary, and the ruptured follicle may continue to secrete 275 
follicular fluid for a short time following ovulation (the developing follicle may also secrete hormones into 276 
the peritoneal cavity for a period prior to ovulation[111]). There is therefore a pool of hormone-enriched fluid 277 
adjacent to the fimbria at the end of the fallopian tube before and after ovulation, and this may be drawn into 278 
the tube by ciliary flow[112, 113] or enter adjacent blood vessels. Since the composition of fallopian tube fluid 279 
differs between left and right sides, and since sperm respond to progesterone concentrations in the picomolar 280 
range,[102, 114] these differences may have implications for sperm chemotaxis. Given that the follicular 281 
microenvironment is virtually saturated with progesterone, the oocyte and its associated cumulus cells are 282 
likely equilibrated to follicular fluid conditions, and the oocyte-cumulus complex itself is also a source of 283 
chemoattractants, including progesterone.[109, 114, 115] We therefore have a situation where the chemoattractant 284 
concentrations within oocyte-cumulus complexes differs between left and right sides, and where the 285 
fallopian tube fluid that bathes these complexes also differs. 286 
With this in mind, there are several ways that ovarian asymmetry (as demonstrated by variation in hormonal 287 
concentrations in follicular fluid from left and right ovaries) might influence human fertility. Firstly, 288 
progesterone can inhibit ciliary beating in the fallopian tube,[116, 117] and so egg motility may differ between 289 
the left and right tubes, with extended migration times reducing the possibility of “healthy” sperm reaching 290 
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the egg. Secondly, different hormone/chemoattractant concentrations on the left and right may affect sperm 291 
chemotaxis, either positively, through improved or earlier attraction of sperm, or negatively, through 292 
saturation of receptors. Saturated receptors can no longer detect increases in chemoattractant concentration, 293 
rendering chemotaxis impossible, and studies of human sperm cell responses to progesterone have indeed 294 
shown that high concentrations are ineffective, and that sperm more readily respond to concentrations in the 295 
picomolar range.[102, 114] These effects may operate over both long (from the sperm reservoir to the oocyte-296 
cumulus complex) or short (within the oocyte-cumulus complex) distances. Similarly, X and Y chromosome-297 
bearing sperm may respond differently to signals from the right and left. There has been much debate over 298 
morphological or behavioural differences between X and Y chromosome-bearing sperm, with some 299 
suggesting that those carrying the smaller Y chromosome may have a smaller head size and swim faster (and 300 
potentially further) than those bearing the larger X chromosome.[118, 119] The difference in DNA content 301 
between X and Y chromosome-bearing sperm is roughly 3%, and, although small, it does seem likely that 302 
this has at least some influence on size and/or shape of the sperm head.[21, 120–122] Sperm carrying X or Y 303 
chromosomes may therefore have either variable numbers of chemoreceptors such as CatSper[123, 124] and 304 
hOR17-4,[125] or these receptors may be distributed differently across the sperm head. A higher number of 305 
receptors on larger X chromosome-bearing sperm might improve sensitivity, whilst a lower number on those 306 
carrying a Y may make them more easily saturated. Variability in receptor distribution across larger or 307 
smaller sperm heads might also improve directionality, or simply improve sensitivity by widening the 308 
detection window. Most importantly, the different intrinsic hormone concentrations of eggs originating in the 309 
left and right ovaries might impact embryonic implantation, placentation, and post-implantation survival and 310 
especially greater survival of female embryos during times of stress when the maternal acceptance threshold 311 
shifts in their favour. 312 
The literature concerning the human sex ratio at birth is very male-centric. Discussion of variation in sex 313 
ratio, and especially declines, typically assumes that this is the result of a greater loss of males (the “fragile 314 
male” idea[126–128]), possibly because most male losses occur later in development, and so are more visible. A 315 
similar result can of course also be explained by more females surviving than would usually be the case. [129] 316 
Such increased survival can affect the sex ratio at birth in several ways, most obviously with a greater 317 
number of female live births, but also by impacting subsequent pregnancies. In those actively trying to 318 
conceive, a female embryo lost early (at or soon after implantation) might have been replaced by a male in a 319 
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subsequent cycle, but survival of the female embryo removes that mother from the pool of potential 320 
reproducers for the duration of the pregnancy, and sometime beyond. Reproductive behaviour may also be 321 
important, particularly in terms of stopping rules,[130] where couples desiring a child of a specific sex stop 322 
reproducing once this is achieved, or where couples might wish for a child of each sex, and continue 323 
reproducing until this is achieved. In conditions which favour survival of females, those seeking a girl might 324 
therefore stop reproducing after one pregnancy, and those who seek a boy and a girl would stop if they 325 
already have a boy. Conversely, those seeking a boy who already have one girl might continue to reproduce 326 
after having another, and, if the stressful conditions endure, may continue to have girls. However, it must be 327 
kept in mind that changes to the human sex ratio at birth are typically small, varying only between a low of 328 
51.02:48.98% male:female in 1927 to a high of 51.58:48.42% male:female in 1973, based on live birth data 329 
for England and Wales from 1927-2017. In the 62,454,461 live births recorded during this period, only 330 
1,685,618 more boys than girls were born. If slightly more boys were conceived (i.e. if the primary sex ratio 331 
at conception was not exactly equal), then this miscarriage sex bias would disappear – althoughy we would 332 
then need a mechanism which would favour greater conception of boys. Whilst ovarian asymmetry and a 333 
threshold dichotomy of implantation and placentation success predicated upon uterine biosensing may not 334 
account for all of the observed variation in miscarriage sex, it does represent a novel mechanism by which 335 
we can explain existing data, such as the influence of maternal hormones around the time of conception, and 336 
the impact of stressful events and seasonality on the human sex ratio at birth. 337 
 338 
Conclusions 339 
Ovarian asymmetry is a neglected aspect of reproductive biology. It is rare to find a scientific publication 340 
dealing with embryos produced by assisted reproductive technology or the composition of follicular fluid 341 
that identifies from which ovary the study materials were sourced.  Similarly, studies of implantation rarely, 342 
if ever, identify the sex of embryos concerned. Research in adult humans, or using animals, is required to 343 
report the participant sex, and it is perhaps time for greater awareness of embryonic sex and ovary-of-origin 344 
in the study of early human development. A greater appreciation of ovarian asymmetry may also be 345 
necessary for explaining variation within and between women (Box 2). Similarly, consideration of testicular 346 
asymmetry, and that of the uterus and fallopian tubes, may also be overdue, as early developmental 347 
asymmetries likely impact all of these structures. 348 
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More girls are lost during pregnancy than boys, and as a result the human sex ratio at birth is biased towards 349 
males. Male and female embryos are not equal from the very moment of conception, and it should be no 350 
surprise that these differences might influence some of the most important aspects of mammalian 351 
development, such as implantation and placentation. The greater genetic and metabolic “differentness” of 352 
female embryos, at least prior to the development of functional gonads, may count against them in the 353 
threshold dichotomy[10] of acceptance or rejection by maternal tissues. Such discrimination may ultimately 354 
work in their favour however, if it follows a pattern similar to that in ‘reverse’ imprinting,[131, 132] where 355 
expression of maternal alleles might be favoured if elevated gene expression increases the possibility of 356 
spontaneous abortion, but leads to an increase in robustness (increased growth and pre- and post-natal 357 
survival) of survivors. If losses occur early in pregnancy, minimal resources have been invested and cost to 358 
the mother is limited. Boys exhibit greater infant mortality than girls[133] (and higher stillbirth rates) and so it 359 
may be that the greater loss of girls earlier in pregnancy actually explains their later robustness. 360 
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Figure 1. Live birth and stillbirth sex ratio in England and Wales, 1927-2017. On average 1,055 males were born per 1,000 females, and there are no years where 
more females are born than boys. The definition of stillbirth changed from 28 weeks of gestation to 24 weeks of gestation in 1992, and on average 1,133 boys were 
stillborn per 1,000 girls between 1927 and 1992, and 1,112 per 1,000 between 1993 and 2017. In the entire dataset, there are only three years where more girls were 









Figure 2. Sex ratio of therapeutic and elective abortions in England and Wales, 1993-2017, determined on the assumption that early (≤12 weeks) abortions are biased 







Figure 3. Relative miscarriage sex bias in England and Wales, 1993-2017, calculated as 1-(females 
miscarried/males miscarried), calculated if 33% of all conceptions result in miscarriage. A value of 0 
indicates no bias, a positive value would show male bias, and a negative value a female bias. Miscarriages 
are biased towards females in every year of this 25 year dataset, with a marked decrease in the miscarriage 
sex ratio around 2005-2006, following the 7th July 2005 terrorist bombings in London, and a smaller dip in 













Table 1. Theoretical prediction of the number of miscarried products of conception in England and Wales in 
2012. Sexual habits are based on Natsal-3[39] for women aged 16-44, and the remaining data are from ONS 
statistical datasets as described in the text. The predicted miscarriage rate is 43% overall, or 38% for women 
aged 20-39 (responsible for the majority of live births, stillbirths and abortions). 
 
 Age 
 Under 20 20-24 25-29 30-34 35-39 All 
Number of women 1362919 1893629 1925992 1898383 1803418 8884341 
Annual acts of vaginal 
sex (assuming 44 per 
woman per year) 
59968436 83319676 84743648 83528852 79350392 390911004 
Annual acts of 
unprotected vaginal sex 
(assuming one in six is 
unprotected) 
9994739 13886613 14123941 13921475 13225065 65151834 
Unprotected acts 
occurring within 48-hour 
period around ovulation 
(i.e. 1/14) 
713910 991901 1008853 994391 944648 4653702 
Assume one in three of 
these results in 
fertilisation 
237970 330634 336284 331464 314883 1551234 
Number of live births to 
these women 
33815 132456 202370 216242 114797 699680 
Number of stillbirths to 
these women 
217 669 936 912 601 3118 
Number of elective and 
therapeutic abortions to 
these women 
30539 54558 41882 30353 18523 145316 
Estimated loss 173399 142951 91096 83957 180962 672364 








Box 1. Calculating the number of missing conceptions. 
Natsal-3[39] suggests that women aged 16-44 in the survey period (6th September 2010 – 31st August 
2012) had on average 4.9 occasions of sexual intercourse (defined as vaginal, oral or anal intercourse) in 
the preceding 4 weeks, of which 69% included vaginal sex (defined as a man’s penis in a woman’s 
vagina). The frequency of sexual intercourse for this age group is likely nearer 1.2 occasions per week, 
with 0.85 instances of vaginal sex per week. The annual frequency (i.e. for 52 weeks) of vaginal sex for 
women aged 16-44 in the survey period was therefore 44.2, not the 104 previously used by Roberts and 
Lowe.[38] The proportion of unprotected acts of coitus during the survey period is also lower than the 
25% estimate of Roberts and Lowe, and is likely nearer 5-7% for women aged 16-44,[134] increasing to 
around 10% if less effective methods of contraception are included, or to 1/6 if some consideration is 
given to those trying to conceive or who were already pregnant. The number of unprotected instances of 
vaginal sex per woman per year is therefore around 7, and, of these, 1/14 will occur within 48 hours of 
ovulation. Given a fertilisation rate of around 60% in in vitro fertilisation,[135] where sperm quality and 
quantity is likely higher than that of a “normal” ejaculate at the point of fertilisation in vivo, a fertilisation 
rate of one in three seems reasonable. The Office for National Statistics mid-year population estimate for 
mid-2012 predicted that there were 8,884,341 women between the ages of 16-39 in England and Wales, 
and so the estimated the number of “missing” conceptions (i.e. those not accounted for in the relevant 
live birth, stillbirth, and legal therapeutic and elective abortion statistics) for women aged 16-39 in 2012 
was 43%. For women aged 20-39 (responsible for 91% of all live births, 88% of stillbirths and 78% of 
abortions), the average rate of loss was 38% (Table 1). Given the inherent uncertainty in these 







Box 2. Quantifying ovarian asymmetry 
We know that the right and left ovaries are not equal. They originate on different sides of an asymmetric 
embryo, and lie in different sides in a directionally asymmetric adult. Differences in venous relations 
suggest that rates of drainage will vary, and we might therefore expect that levels of various hormones 
and metabolites might also vary. What is needed now is direct measurement of these variations. Whilst 
this may seem a relatively simple experiment, requiring only collection of follicular fluid from the left 
and right ovaries of a large number of women during assisted-reproduction, it is complicated by the fact 
that every ovulation changes the ovary, forever, converting a primordial follicle into a fibrous, scar-like 
corpus albicans. However, ovaries do not endlessly accumulate corpora albicantia, and those of 
premenopausal women undergo a process of fibroblastic replacement, ultimately forming a new section 
of ovarian connective tissue (stroma). Given different patterns of right/left ovulation between women, 
and with variable gaps related to childbirth or contraception, it becomes clear that we should be very 
careful when comparing ovaries between even age-matched women. How then might we quantify 
ovarian asymmetry in the face of differential patterns and numbers of ovulations? The simplest approach 
seems to be to go earlier, and to investigate inherent ovarian asymmetry before the onset of puberty, 
through measurement of levels of hormones and metabolites in the left and right ovaries with respect to 







































Data for numbers of maternities, live births and stillbirths, including numbers of males and females, were 
collected from the Office for National Statistics (https://www.ons.gov.uk/) ‘Review of the Registrar General 
on births and patterns of family building in England and Wales’, Series FM1 (numbers 22-37, covering 
1993-2008), the ‘Characteristics of Birth 2, England and Wales’ dataset (2009-2013), the ‘Birth 
characteristics dataset’ (2014-2016), and the ‘Summary of key birth statistics, 1838 to 2017’. Data on 
numbers of legal abortions from 2011-2017 were obtained from the Department of Health and Social Care 
(DHSC) ‘Abortion statistics, England and Wales’ collection 
(https://www.gov.uk/government/collections/abortion-statistics-for-england-and-wales), and for 1993-2010 
from the UK Government Web Archive (http://www.nationalarchives.gov.uk/webarchive/). Numbers of 




England and Wales population data were obtained from the ‘MYE2: Population Estimates by single year of 
age and sex for local authorities in the UK, mid-2012’ 
(https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datas
ets/populationestimatesforukenglandandwalesscotlandandnorthernireland). 
Gestation week data is variable across the abortion dataset, and so statistics were pooled into abortions 
occurring either ≤12 weeks or ≥13 weeks. A comprehensive study of the human sex ratio from conception to 
birth[29] supports a female-biased cohort sex ratio during early pregnancy based on chorionic villus sampling, 
amniocentesis and induced abortions, and I have therefore chosen a conservative estimate of a 55:45 
female:male sex ratio ≤12 weeks and 45:55 female:male ≥13 weeks. Using these values, I calculated the 
number of male and female abortuses each year.  
Adding together the total number of live births, stillbirths and legal abortions provided the number of 
pregnancies, and accepting that these represent 67% of actual conceptions (i.e. the probability that a 
conception resulted in miscarriage was 33%) determined the relevant number of conceptions. If the primary 
sex ratio is equal, then equal numbers of males and females are conceived, and subtraction of the known 
28 
 
numbers of live and stillborn males and females, and the predicted male and female abortuses left the 
number of products of conception lost to miscarriage.  
Statistical significance of deviation of calculated numbers of miscarried males and females from expected 
numbers (males and females are equally susceptible to miscarriage) was assessed using Pearson’s χ2 test. All 
calculations were rounded to the nearest whole number to reflect the impossibility of conceiving a fraction of 
a person, and so in some cases annual totals are not the sum of their constituent parts. It also goes without 
saying that the ratios presented here address only a narrow range of biological sex, not gender, and are 








Supplemental table S1. Live births, stillbirths and abortions in England and Wales, 1993-2017. Numbers of males and females for live births and stillbirths reflect 
classifications as recorded on the relevant birth registers. Abortus sex is calculated from the total number of therapeutic and elective abortions on the assumption that the 
sex ratio ≤12 weeks of gestation is 55:45 in favour of females, and 45:55 in favour of males from ≥13 weeks of gestation. Total or average values are provided in the bottom 
rows. 
Year Live births Stillbirths Abortions 
Total (live births + stillbirths + 
abortions)  Total Female Male 
Male live births 
per 1,000 female 
live births 
Total Female Male 
Male stillbirths per 
1000 female 
stillbirths 
Total Female Male 
Male abortuses 
per 1000 female 
abortuses 
1993 673467 327632 345835 1056 3855 1779 2076 1167 157846 85072 72775 855 835168 
1994 664726 323405 341321 1055 3813 1779 2034 1143 156539 84363 72176 856 825078 
1995 648138 315950 332188 1051 3600 1688 1912 1133 154315 83211 71104 854 806053 
1996 649485 315995 333490 1055 3539 1731 1808 1044 167916 90444 77472 857 820940 
1997 642093 313021 329072 1051 3439 1638 1801 1100 170145 91732 78413 855 815677 
1998 635901 309998 325903 1051 3417 1595 1822 1142 177871 95875 81996 855 817189 
1999 621872 302617 319255 1055 3305 1578 1727 1094 173701 93634 80067 855 798878 
2000 604441 294816 309625 1050 3203 1472 1731 1176 175542 94485 81057 858 783186 
2001 594634 289999 304635 1050 3159 1434 1725 1203 176364 94851 81513 859 774157 
2002 596122 290059 306063 1055 3372 1565 1807 1155 175932 94542 81390 861 775426 
2003 621469 303041 318428 1051 3585 1711 1874 1091 181582 97557 84025 861 806636 
2004 639721 311381 328340 1054 3686 1736 1950 1123 185415 99690 85725 860 828822 
2005 645835 315235 330600 1049 3483 1687 1796 1065 186416 100535 85881 854 835734 
2006 669601 327172 342429 1047 3602 1741 1861 1069 193737 104469 89268 854 866940 
2007 690013 335525 354488 1057 3598 1691 1907 1128 198499 107139 91360 853 892110 
2008 708711 345748 362963 1050 3617 1722 1895 1100 195296 105514 89782 851 907624 
2009 706248 344113 362135 1052 3688 1730 1958 1132 189100 103114 85986 834 899036 
2010 723165 352199 370966 1053 3714 1745 1969 1128 189574 102582 86992 848 916453 
2011 723913 352939 370974 1051 3811 1791 2020 1128 189931 102787 87144 848 917655 
2012 729674 355328 374346 1054 3558 1674 1884 1125 185122 100150 84972 848 918354 
2013 698512 340129 358383 1054 3284 1565 1719 1098 185331 100360 84971 847 887127 
2014 695233 338461 356772 1054 3254 1602 1652 1031 184571 99998 84573 846 883058 
2015 697852 339716 358136 1054 3147 1498 1649 1092 185824 100649 85175 846 886823 
2016 696271 339225 357046 1053 3112 1560 1552 995 185596 100501 85095 847 884979 
2017 679106 331035 348071 1051 2873 1347 1526 1133 189859 102488 87371 853 871838 
Total: 16656203 8114739 8541464 - 86714 41059 45655 - 4512024 2435740 2076284 - 21254941 








Supplemental table S2. Predicted spontaneous abortions (miscarriages) in England and Wales, 1993-2017. The number of conceptions is calculated on the assumption that 
the sum of live births, stillbirths and elective and therapeutic abortions represents 67% of all conceptions (i.e. 33% of conception are lost). The sex ratio at conception is 
equal, and so the number of miscarriages can be calculated from the number of males or females conceived and the number accounted for in live birth, stillbirth or 
abortion statistics. Total or average values are provided in the bottom rows. 
 
  Number of conceptions 
Number of conceptions accounted for in 
live birth stillbirth and abortion data 
Number of miscarriages 
  Total Female Male Total Female Male Total Female Male 
Male miscarriages per 
1000 female 
miscarriages 
1993 1110773 555387 555387 835168 414483 420686 275605 140904 134701 956 
1994 1097354 548677 548677 825078 409547 415531 272276 139130 133146 957 
1995 1072050 536025 536025 806053 400849 405204 265997 135176 130822 968 
1996 1091850 545925 545925 820940 408170 412770 270910 137755 133155 967 
1997 1084850 542425 542425 815677 406391 409286 269173 136034 133139 979 
1998 1086861 543431 543431 817189 407468 409721 269672 135963 133709 983 
1999 1062508 531254 531254 798878 397829 401049 263630 133425 130205 976 
2000 1041637 520819 520819 783186 390773 392413 258451 130046 128405 987 
2001 1029629 514814 514814 774157 386284 387873 255472 128531 126941 988 
2002 1031317 515658 515658 775426 386166 389260 255891 129492 126399 976 
2003 1072826 536413 536413 806636 402309 404327 266190 134104 132086 985 
2004 1102333 551167 551167 828822 412807 416015 273511 138360 135151 977 
2005 1111526 555763 555763 835734 417457 418277 275792 138306 137486 994 
2006 1153030 576515 576515 866940 433382 433558 286090 143133 142957 999 
2007 1186506 593253 593253 892110 444355 447755 294396 148898 145498 977 
2008 1207140 603570 603570 907624 452984 454640 299516 150586 148930 989 
2009 1195718 597859 597859 899036 448957 450079 296682 148902 147780 992 
2010 1218882 609441 609441 916453 456526 459927 302429 152915 149514 978 
2011 1220481 610241 610241 917655 457517 460138 302826 152724 150102 983 
2012 1221411 610705 610705 918354 457152 461202 303057 153554 149503 974 
2013 1179879 589939 589939 887127 442054 445073 292752 147885 144867 980 
2014 1174467 587234 587234 883058 440061 442997 291409 147172 144237 980 
2015 1179475 589737 589737 886823 441863 444960 292652 147874 144777 979 
2016 1177022 588511 588511 884979 441286 443693 292043 147225 144818 984 
2017 1159545 579772 579772 871838 434870 436968 287707 144903 142804 986 
Total: 28269072 14134536 14134536 21254941 10591538 10663403 7014131 3542998 3471133  - 
Average: 1130763 565381 565381 850198 423662 426536 280565 141720 138845 980 
 
